Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Zandatrigine by Neurocrine Biosciences for Epileptic Encephalopathy: Likelihood of Approval
Zandatrigine is under clinical development by Neurocrine Biosciences and currently in Phase II for Epileptic Encephalopathy. According to GlobalData, Phase...